890 studies found for:    "Carcinoma, Hepatocellular"
Show Display Options
RSS Create an RSS feed from your search for:
"Carcinoma, Hepatocellular"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
2 Terminated SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatoma
Intervention: Device: SIR-Spheres microspheres
3 Recruiting Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatoma;   Liver Cancer, Adult;   Liver Cell Carcinoma, Adult
Intervention: Drug: TKM-080301
4 Active, not recruiting Combination SBRT (Stereotactic Body Radiotherapy) With TACE (Transarterial Chemoembolization) for Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatobiliary Neoplasm;   Liver Carcinoma
Interventions: Procedure: TACE;   Procedure: SBRT
5 Terminated Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
Conditions: Cancer;   Liver Cancer;   Primary Liver Cancer;   Hepatocellular Carcinoma;   Hepatoma
Interventions: Drug: PI-88;   Drug: placebo
6 Recruiting A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Conditions: Liver Tumors;   Hepatocellular Carcinoma;   Hepatoma;   Neoplasms
Intervention: Device: TheraSphere®
7 Unknown  Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma;   Metastatic Hepatocellular Carcinoma
Intervention: Drug: Sorafenib with Capecitabine and Oxaliplatin
8 Active, not recruiting Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Hepatoma
Interventions: Device: Bead Block microspheres;   Other: Bead + Dox Arm
9 Recruiting the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma
Conditions: Stage I Hepatocellular Carcinoma;   Stage II Hepatocellular Carcinoma
Interventions: Drug: the ginsenoside Rg3;   Drug: Placebo
10 Recruiting Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
Conditions: Cirrhosis With Hepatocellular Carcinoma;   Cirrhosis Without Hepatocellular Carcinoma
Interventions: Biological: Serum, plasma and DNA samples;   Procedure: Radiological exploration by CT scan or MRI
11 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular
Interventions: Drug: TRC 105;   Drug: Sorafenib
12 Recruiting A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
Conditions: Advanced Adult Hepatocellular Carcinoma;   Hepatocellular Carcinoma Metastatic
Intervention: Drug: AZD9150
13 Active, not recruiting Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatoma
Interventions: Drug: sorafenib;   Procedure: LC Bead-TACE
14 Withdrawn Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatocellular Cancer;   Hepatoma;   Liver Cancer
Interventions: Drug: Sorafenib;   Radiation: Conventional fractionation (2 Gy per day) external beam radiation therapy
15 Recruiting Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib
Conditions: Hepatocellular Carcinoma;   Unresectable Hepatocellular Carcinoma;   Carcinoma, Hepatocellular;   Liver Neoplasm
Interventions: Drug: TACE with sorafenib;   Procedure: TACE alone
16 Completed A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
17 Recruiting Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: epirubicin;   Drug: Cisplatin
18 Recruiting Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Transarterial Chemoembolization;   Radiation: Proton Beam Radiotherapy
19 Unknown  Proteomic Analysis of Human Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: Operation
20 Completed PI-88 in Hepatocellular Carcinoma After Hepatectomy
Condition: Carcinoma, Hepatocellular
Intervention: Drug: PI-88

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years